Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement
Cannabis Law Report
NOVEMBER 10, 2021
Once completed, it is our intention to immediately submit our IND package to the FDA so that we may begin human trials,” commented Virpax’s Chairman & CEO Anthony P. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Forward-Looking Statement.
Let's personalize your content